Variant report
Variant | esv19992 |
---|---|
Chromosome Location | chr3:69179922-69181540 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ARL6IP5-3 | chr3:69180049-69180447 | predAs_chen_BG208742_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529048079 | chr3:69179930-69179931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530010508 | chr3:69179978-69179979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542749590 | chr3:69179994-69179995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144120579 | chr3:69180000-69180001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370371178 | chr3:69180021-69180022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs145001268 | chr3:69180071-69180072 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs149074614 | chr3:69180159-69180160 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs188747708 | chr3:69180181-69180182 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs180771568 | chr3:69180211-69180212 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs6774962 | chr3:69180218-69180219 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs34399740 | chr3:69180281-69180282 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs367875306 | chr3:69180282-69180283 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs557995328 | chr3:69180283-69180284 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs79063258 | chr3:69180297-69180298 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs71115651 | chr3:69180299-69180300 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs567126807 | chr3:69180367-69180368 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs185410937 | chr3:69180368-69180369 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs536001678 | chr3:69180407-69180408 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs548464460 | chr3:69180422-69180423 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs549081371 | chr3:69180437-69180438 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs200954608 | chr3:69180438-69180439 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs143296839 | chr3:69180565-69180566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534737979 | chr3:69180570-69180571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368341323 | chr3:69180572-69180573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114663206 | chr3:69180573-69180574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372101174 | chr3:69180620-69180621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs148317457 | chr3:69180664-69180665 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537749544 | chr3:69180730-69180731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375975420 | chr3:69180788-69180789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557644431 | chr3:69180789-69180790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574297160 | chr3:69180790-69180791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543212569 | chr3:69180851-69180852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548488044 | chr3:69180899-69180900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141572314 | chr3:69180904-69180905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9875086 | chr3:69180908-69180909 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs544717446 | chr3:69180924-69180925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190563162 | chr3:69180943-69180944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530379064 | chr3:69180947-69180948 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374621598 | chr3:69180982-69180983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs535926077 | chr3:69180985-69180986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531938324 | chr3:69181004-69181005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368626657 | chr3:69181017-69181018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372316069 | chr3:69181033-69181034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529861105 | chr3:69181037-69181038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140875716 | chr3:69181048-69181049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546367983 | chr3:69181057-69181058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7644952 | chr3:69181064-69181065 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs535110865 | chr3:69181065-69181066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551533475 | chr3:69181107-69181108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs568362527 | chr3:69181140-69181141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Breast cancer | 21509527 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Autism | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Prostate cancer | 17217626 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Mental retardation | 20848658 | CNVD |
Breast cancer | 17142309 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Melanoma | 20877625 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:69178000-69193600 | Weak transcription | Psoas Muscle | Psoas |
2 | chr3:69178400-69180000 | Weak transcription | Placenta | Placenta |
3 | chr3:69179200-69180000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
4 | chr3:69180000-69180200 | Enhancers | Placenta | Placenta |
5 | chr3:69180000-69180200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr3:69180000-69180400 | Enhancers | GM12878-XiMat | blood |
7 | chr3:69180200-69180600 | Weak transcription | Placenta | Placenta |
8 | chr3:69180200-69190600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
9 | chr3:69180600-69181000 | Enhancers | Placenta | Placenta |